ADVERTISEMENT
The Story Of Extortive Prices For Cancer Drugs And Whether The Government Has Done Enough
08 Apr 2019, 06:53 PM IST
Price regulation of medicines and pharmaceutical products is an unlikely topic for pre-election discussions. Nevertheless, given the many efforts at price regulation in the pharmaceutical sector, it is likely to be the case this year. In order to control the very high trade margins that hamper price competition in the pharmaceutical sector, the Indian government recently capped trade margins of brands of 42 anti-cancer medicines.
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Full Access to
NDTV Profit App
Exclusives
Premium Stories
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Minimal Ad
Experience
Members-Only
Rewards
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT